Daily Stock List
Silver Bull Resources, Inc. (SVBL)
TopPennyStockMovers, Wall Street Resources, RedChip, Streetwise Reports, Stockhouse, StreetInsider, and Stock Stars reported on Silver Bull Resources, Inc. (SVBL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Silver Bull Resources, Inc. is a mineral exploration company headquartered in Vancouver, British Columbia. Its flagship project is "Sierra Mojada". This Project is located150 kilometers north of the city of Torreon in Coahuila, Mexico. The Project is highly prospective for silver and zinc. An exploration stage enterprise, the Company previously went by the name Metalline Mining Company. It changed its name to Silver Bull Resources, Inc. in April 2011.
The Company’s Sierra Mojada Project is 100 percent owned and operated by Silver Bull Resources. It is part of a large land package comprising 40 mining concessions totaling 21,167 hectares (52,305 acres), situated in an historical high grade silver, lead, zinc mining district discovered in 1879. Sierra Mojada has premier infrastructure. This infrastructure includes a railway to the site; a paved road; grid power, and five company-owned water wells.
The main mineralization zone found at Sierra Mojada extends greater than six kilometers in an East-West direction along the base of the Sierra Mojada Range parallel with the Sierra Mojada fault. More than 54 historical mine shafts lie along this strike, mining to depths over 200 meters. This area has not been mined with modern mining technology and processes. Sierra Mojada is an open pittable oxide deposit.
Silver Bull Resources announced in June of 2015 that it identified more high grade massive sulphide mineralization at its Sierra Mojada Project. The new sulphide mineralization lies within a 1.4-kilometer-long east-west trending chargeability anomaly identified in a "Gradient Array IP survey" completed in 2010 by Zonge Engineering and Research Organization, Inc. Silver Bull Resources identified new massive sulphide mineralization grading 690G/T Silver, 1% Copper, 4.8% Lead and 15.25% Zinc at the Sierra Mojada Project.
The Sierra Mojada Project has an NI 43-101 compliant measured and indicated Global resource of 58.7 million tonnes grading at 3.6% zinc and 50 g/t silver for 4.670 billion pounds of zinc and 90.8 million ounces of silver.
Silver Bull Resources states that mineralization at Sierra Mojada has strong analogies with several different deposit styles. This includes Carbonate Replacement Deposits (CRD), Irish-type deposits, and possibly Mississippi Valley Type (MVT). An intrusive system has yet to be found. However, the Company says that elevated copper, molybdenum, arsenic, and mercury in the area all point to a likely intrusive source.
Silver Bull Resources, Inc. (SVBL), closed Tuesday's trading session at $0.09475, down 0.26%, on 272,813 volume with 25 trades. The average volume for the last 60 days is 353,558 and the stock's 52-week low/high is $0.0217/$0.145.
Quantum Materials Corp. (QTMM)
Stock News Now, SmallCapVoice, and TopPennyStockMovers reported earlier on Quantum Materials Corp. (QTMM), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
San Marcos, Texas-based Quantum Materials Corp. manufactures Tetrapod Quantum Dots for use in medical, display, solar energy, and lighting applications through its patent-pending volume production process. Tetrapod Quantum Dot semiconductors allow for a new level of engineered performance for consumer and industrial products. Quantum Materials has its wholly-owned subsidiary, Solterra Renewable Technologies, Inc. Solterra focuses on making solar cells for retail electricity markets in North America, Europe, the Middle East, and Asia.
Quantum dots fall into the category of nanocrystals. This also includes quantum rods and nanowires. Quantum Dots measure near one billionth of an inch. They are a non-traditional type of semiconductor. They can be utilized as an enabling material across many industries. They have premier versatility and are flexible in form.
The Company’s Solterra Renewable Technologies develops sustainable solar technology through replacing silicon wafer-based solar cells with high-production, low-cost, efficient and flexible thin-film quantum dot solar cells. Its goal is to market a thin-film photovoltaic cell incorporating its proprietary quantum dot semiconductors.
Solterra Renewable Technologies will use Quantum Materials’ exclusive license from University of Arizona Regents for Dr. Ghassan Jabbour’s patented printing technology in the production of its solar cells. Solterra’s aim is to become the first solar cell manufacturer, which can provide a solar electricity solution that competes on a non-subsidized basis with the price of retail electricity in the aforementioned key markets.
Quantum Materials has secured 3D printing and additive manufacturing anti-counterfeiting quantum dot detection technology. This was developed at the Institute for Critical Technology and Applied Science and the Design, Research, and Education for Additive Manufacturing Systems (DREAMS) Laboratory at Virginia Tech. This technology embeds quantum dots within objects being 3D printed to produce a unique, physically uncloneable signature known only to the object's manufacturer.
Quantum Materials has launched its new QDX™ class of high-stability Cadmium-free quantum dots. QDX™ Quantum Dots do not degrade under the high heats used in application to film, silicon, and polymer. They allow for creative LCD display and LED lighting engineering and lowering protective barrier film costs.
In a presentation on March 9, 2016 at the Smithers Apex’s 4th Annual Quantum Dots Forum in Newport Beach, California, Dr. Nathan Stott, Quantum Materials’ Director of Materials, outlined the Company's objectives for increasing the efficiency and commercial viability of solar energy production via the integration of quantum dots into thin-film solar cells.
Dr. Stott’s presentation entitled ‘Quantum Dot Solar: Meeting Emerging Strong Market Demand’
lays out the Company’s goal of decreasing estimated solar energy generation costs by 50 percent through the integration of quantum dots manufactured with Quantum Materials’ continuous flow production and high speed roll-to-roll printing technology. The Company said that this combination has the potential to considerably lessen manufacturing equipment capital expenditures required to manufacture solar cells by up to 75 percent in comparison to present solar cell production technologies.
Quantum Materials Corp. (QTMM), closed Tuesday's trading session at $0.16, down 3.03%, on 1,146,762 volume with 92 trades. The average volume for the last 60 days is 342,509 and the stock's 52-week low/high is $0.085/$0.22.
Pressure BioSciences, Inc. (PBIO)
SmallCapFinancialWire, Stock News Now, SECFilings.com News, Marketbeat.com, SmallCapVoice, HotStockProfits, Equity Observer, Value Penny Stocks, Jet-Life Penny Stocks, TopPennyStockMovers, and PennyStocks24 reported earlier on Pressure BioSciences, Inc. (PBIO), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Pressure BioSciences, Inc. centers on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology (PCT). PCT is a patented, enabling technology platform with many applications in the life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. Pressure BioSciences is headquartered in South Easton, Massachusetts.
The Company is focusing its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications. Its primary application development and sales efforts are in the biomarker discovery, drug discovery and design, and forensics areas. To date (as of April 6, 2016), the Company has installed greater than 250 PCT systems in roughly 160 sites around the world.
The PCT Sample Preparation System (PCT SPS) allows for the safe, fast, and reproducible extraction of DNA, RNA, small molecules, and proteins from a broad variety of cells and tissues, particularly those considered ‘hard-to-lyse’. The PCT SPS employs a Barocycler NEP3220, in concert with PULSE™ Tubes.
Pressure BioSciences’ products include Barocycler Instruments, Shredders, PULSE Tubes (PT), PCT MicroTubes and PCT MicroCaps, PCT µPestle System, The Barozyme™ HT48, and also Kits & Reagents. Furthermore, Pressure BioSciences is an authorized distributor of Constant Systems Ltd. products in the U.S., Mexico, and Canada.
The Barozyme HT48 is a first-in-class, high throughput, PCT-based instrument. It can process up to 48 samples at the same time utilizing the Company’s proprietary BaroFlex 8-well, single-use processing strips. Together, the new Barozyme HT48 instrument and BaroFlex 8-well processing strips make up the Barozyme HT48 High-throughput System (the Barozyme HT48 System).
In January 2015, SCIEX announced an exclusive co-marketing agreement with Pressure BioSciences. SCIEX said that the relationship will uniquely position it to address a major challenge in complex sample preparation through marketing a total solution to increase the depth, breadth, and reproducibility of protein extraction, digestion and quantitation in all tissue types, including challenging samples like tumors. SCIEX is a global leader in life science analytical technologies.
With the Agreement, Pressure BioSciences and SCIEX will promote pressure cycling technology (PCT) sample preparation systems such as PCT-HD (PCT High Definition) with SWATH® Acquisition based next-generation proteomics, TripleTOF® Systems, QTRAP® Systems, and Triple Quad Systems.
Pressure BioSciences’ near-term goals (FY2016) include completing the manufacture of the Barocycler NEP2320 Extreme and commencing the commercialization plan for this new pressure-generating instrument. Its goals (among others) also include supporting and expanding its co-marketing program with SCIEX; securing a strategic marketing and distribution partner for the Barozyme HT48 high throughput system and for the NMR and EPR PCT-based sample preparation systems.
Pressure BioSciences, Inc. (PBIO), closed Tuesday's trading session at $0.405, down 4.04%, on 51,858 volume with 14 trades. The average volume for the last 60 days is 61,428 and the stock's 52-week low/high is $0.20/$0.58.
Sigma Labs, Inc. (SGLB)
PennyStocks24, Pennybuster, Top Stock Picks, and SuperNova Elite reported earlier on Sigma Labs, Inc. (SGLB), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and research and development (R&D) solutions. It is a foremost developer of proprietary In-Process Quality Assurance™ (IPQA®) software for additive manufacturing (AM). The Company is a developer of advanced, in process, non-destructive quality inspection systems for metal-based AM and other advanced manufacturing technologies The Company is headquartered in Santa Fe, New Mexico.
Sigma Labs consists of top scientists and engineers from Los Alamos National Laboratory. In addition, Sigma Labs serves as an AM contract manufacturer. It centers on bringing novel and advanced materials and manufacturing technologies out of the nation's top National Labs and into the market to serve the aerospace, defense, biomedical, power generation, and general industrial sectors.
Sigma Labs has present contracts with Federal Government and private industry clients. These contracts are to develop technologies from their conception through the design, building, and testing of prototype systems through integrating sensing, software, materials, and also manufacturing technology risk-reduction solutions. Its methodology will be to commercialize technologies via partnerships, joint development, and licensing with other firms.
These technologies include its inventive PrintRite3D® technology. This technology will permit metals parts to be built by 3D printing or additive manufacturing with fewer flaws and better properties.
Last month, Sigma Labs announced that it is teaming with Spartacus3D to speed up its presence in Europe. With this agreement, Spartacus3D will serve as a demonstration, test, as well as evaluation site for Sigma Labs’ PrintRite3D® commercialization and market adoption activities in Europe. Spartacus3D is a unit of France’s Farinia Group and it manufactures components with high-quality metal powder through selective laser melting.
Sigma Labs will host a conference call to discuss the financial results for its Q1 Fiscal 2016. The conference call will take place Thursday, May 12, 2016, at 11:00 a.m. Eastern Time (ET). Sigma Labs plans to release its 2016 Q1 results before market open that same day.
Sigma Labs, Inc. (SGLB), closed Tuesday's trading session at $4.60, up 5.75%, on 1,571 volume with 12 trades. The average volume for the last 60 days is 5,201 and the stock's 52-week low/high is $2.80/$80.00.
VistaGen Therapeutics, Inc. (VSTA)
MissionIR, Tip.us, PennyStocks24, and Wall St. Insider Stocks reported previously on VistaGen Therapeutics, Inc. (VSTA), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical based in South San Francisco, California. The Company’s commitment is to developing and commercializing novel medicines to treat depression, cancer and diseases and disorders involving the central nervous system (CNS). VistaGen’s shares trade on the OTC Markets Group’s OTCQB.
The Company is among the first generation of companies using pluripotent stem cell technology for potential commercial applications focused on producing proprietary new chemical entities (NCEs) by way of drug rescue and regenerative therapies for diseases and conditions related to blood, cartilage, heart, and liver cells.
VistaGen Therapeutics’ lead program is AV-101. Its AV-101 is a new generation orally available NMDAR GlyB antagonist in Phase 2 clinical development for the adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to standard antidepressant therapies. Moreover, AV-101 (based on preclinical studies) may have potential as a treatment for other CNS-related conditions. This includes chronic neuropathic pain and epilepsy, and also neurodegenerative diseases such as Parkinson's disease and Huntington's disease.
VistaGen announced in December 2015 that it secured exclusive worldwide commercial rights to three patent-pending stem cell technologies from University Health Network (UHN). The newly licensed technologies were discovered and developed by eminent UHN researcher, Dr. Gordon Keller, Director of UHN's McEwen Centre for Regenerative Medicine (McEwen Centre), one of the world's top centers for stem cell and regenerative medicine research. UHN is Canada's largest research hospital.
The technologies relate to the development of stem cells into heart, liver and cartilage cells for multiple potential commercial applications. These include drug rescue and regenerative therapies for heart disease, liver disease and osteoarthritis. VistaGen presently holds five licenses to stem cell technologies developed in collaboration with UHN, the McEwen Centre and Dr. Keller.
Recently, VistaGen Therapeutics announced that it appointed Jerry Gin, Ph.D., MBA to its Board of Directors. Additionally, Dr. Gin was appointed as a member of VistaGen's Audit Committee. Dr. Gin has more than 45 years of experience in the healthcare industry, concentrating on founding and developing pharmaceutical, diagnostic, as well as biotechnology companies. He is currently the Co-Founder and Chief Executive Officer of Nuvora, Inc., a private company.
VistaGen Therapeutics, Inc. (VSTA), closed Tuesday's trading session at $5.50, down 21.43%, on 8,398 volume with 16 trades. The average volume for the last 60 days is 1,740 and the stock's 52-week low/high is $4.00/$16.50.
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $1.90, off by 5.47%, on 2,932 volume with 14 trades. The stock’s average daily volume over the past 60 days is 5,719, and its 52-week low/high is $1.10/$9.99.
Monaker Group, Inc. announced today that it has engaged corporate communications firm DreamTeamNetwork ("DTN"). Austin, Texas-based DTN has assisted more than 300 public companies fine tune their corporate communications strategies, which includes investor relations, public relations, and social media relations, as well as branding and marketing, video production and website development. "As we continue to advance our business model and dig our heels into key niches of the travel industry, communication with our shareholders has never been more important," says Monaker Chairman and Chief Executive Officer Bill Kerby. "By partnering with DTN we have the opportunity to focus on both short and long-term corporate initiatives while strengthening our corporate message."
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Group, Inc. (MKGI) Announces Engagement of DreamTeamNetwork Corporate Communications Service Suite
Monaker Groups Booking Technology Unlocks Specialty Lodging Inventory
Monaker Group Engages Primero Systems, a Globally Recognized Award-Winning Technology Solutions Provider
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $2.96, up 2.78%, on 11,553 volume with 40 trades. The stock’s average daily volume over the past 60 days is 6,315, and its 52-week low/high is $1.25/$8.70.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces 2015 Fourth Quarter and Year-End Results
International Stem Cell Corporation to Raise $6.3 Million Through a Private Placement to Fund Phase I Clinical Trial
International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC
OurPet's Company (OPCO)
The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.9154, up 1.71%, on 15,750 volume with 10 trades. The stock’s average daily volume over the past 60 days is 5,992, and its 52-week low/high is $0.60/$1.60.
OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.
In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.
The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.
OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer
OurPet's Company Company Blog
OurPet's Company News:
OurPetís Company Reports Record 2016 First Quarter Results
Ourpet's Company Reaches a Settlement With Competitor Over Durapet(R) Patents
OurPet's Company Unveils New Innovative Products at Global Pet Expo 2016
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $1.9216, up 1.14%, on 26,409 volume with 38 trades. The stock’s average daily volume over the past 60 days is 11,361, and its 52-week low/high is $0.51/$2.20.
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
eXp World Holdings Real Estate Brokerage Division Appoints CEO and President
eXp Realty Launches in 4 More States and the District of Columbia
MissionIR Exclusive Audio Interview With eXp World Holdings, Inc. (EXPI) Chief Executive Officer
Agora Holdings, Inc. (AGHI)
The QualityStocks Daily Newsletter would like to spotlight Agora Holdings, Inc. (AGHI). Today, Agora Holdings, Inc. closed trading at $0.209701, up 4.85%, on 79,034 volume with 39 trades. The stock’s average daily volume over the past 60 days is 251,547, and its 52-week low/high is $0.03/$2.50.
Agora Holdings, Inc. (AGHI), together with its wholly-owned subsidiary, Geegle Media, is leading a diversified family entertainment and media enterprise through business segments which include: TV on Demand, interactive media, business products and consumer platforms. With its multi-dimensional approach, Geegle Media supports Agora Holdings' mission to deliver innovate and high-quality business solution products and to deliver video content from around the world.
Geegle Media web platforms include; GeegleTV, Frame, 1000Salads, RealtyTV and LobbyTV. Geegle TV is a multi-platform video entertainment website that curates high-quality video content from around the world. In 2016, GeegleTV will serve as co-producer by airing original content. By exposing undiscovered content to millions of users and rendering it shareable to social media, Geegle TV will serve as a marketing partner to local and internationally based TV shows not yet on the open market.
For commercial use, Geegle Media provides a variety of solutions that include web development and billing software for VoIP applications. RealtyTV is its state-of-the-art platform for real estate brokerages. LobbyTV is another of its widely used products by business offices. For individuals, Geegle TV combines radio, On Demand movies, news, sports and children's content.
Geegle Media is also developing 1000salads, an online hub that encourages healthy lifestyles. The portal will feature recipes and products, health-oriented articles and a curated selection of local restaurants and grocers that deliver to the health-conscious user. Currently in its alpha stage of development, 1000salads is gearing up its sales and marketing in preparation for its launch in 2016.
Geegle Media differs from other On Demand providers, such as Netflix and HBO, in that its service is free of constraints such as subscription, fees and penalties. As consumers increasingly opt for personalized sources of entertainment, Agora recognizes the vast opportunities and growth potential provided by the rising popularity of TV On Demand. The company also benefits from strong and visionary management with a track record of bringing innovative ideas to fruition. Disclaimer
Agora Holdings, Inc. Company Blog
Agora Holdings, Inc. News:
Agora Holdings, Inc. Updates Shareholders on FRAME Technology, Accounting Audit
Agora Holdings Inc. Signs Engagement Letter With Auditing Firm, BF Borgers CPA PC
Agora Holdings, Inc. to Introduce Details of New Platform Next Week
Today's Top 3
Penny Stock Hub
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Agora Holdings, Inc. (AGHI) Updates Shareholders on FRAME Technology, Accounting Audit
- Alternet Systems (ALYI) Data Analytics Solution Gains Momentum with New Clients and Partners
- Cherubim Interests, Inc. (CHIT) Moving Ahead of Averages, Technical Review -- Research on Saleen Automotive, Cherubim Interests, Fission Uranium, and Pure Biosciences
- Dominovas Energy Corp. (DNRG) Launches the First Rubicon SOFC Project in South Africa
- eXp World Holdings, Inc. (EXPI) Real Estate Brokerage Division Appoints CEO and President
- FlexWeek, Inc. (FXWK) Stay in Vacation Homes around the World for Less than the Cost of Hotels
- Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview
- International Stem Cell Corp. (ISCO) Announces 2015 Fourth Quarter and Year-End Results
- Laguna Blends Inc. (LAGBF) Announces Mr. Ray Grimm Jr. as New President
- Momentous Entertainment Group, Inc. (MMEG) Completes First Music Video
- Monaker Group, Inc. (MKGI) Announces Engagement of DreamTeamNetwork Corporate Communications Service Suite
- Moxian, Inc. (MOXC) Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data
- Oakridge Global Energy Solutions, Inc. (OGES) and CEO Steve Barber to Commence a 3 Part, 90-Minute TV Series -- "Power Up America"
- OurPet's Company (OPCO) Reports Record 2016 First Quarter Results
- Star Mountain Resources Inc. (SMRS) Subsidiary Secures $500,000 Loan From a New York Public Benefit Trust